Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000147530 | SCV000194975 | likely benign | not specified | 2013-01-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001067060 | SCV001232092 | uncertain significance | GLUT1 deficiency syndrome 1, autosomal recessive | 2024-01-19 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 249 of the SLC2A1 protein (p.Arg249Gln). This variant is present in population databases (rs587784395, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with SLC2A1-related conditions. ClinVar contains an entry for this variant (Variation ID: 159927). Advanced modeling performed at Invitae incorporating data from internal and/or published experimental studies (Invitae) indicates that this missense variant is not expected to disrupt SLC2A1 function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Mayo Clinic Laboratories, |
RCV001507438 | SCV001712990 | uncertain significance | not provided | 2020-11-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002390305 | SCV002668866 | likely benign | Inborn genetic diseases | 2019-10-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |